RI Independently Activates Smad-and CD 2 AP-Dependent Pathways in Podocytes

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Renal gene and protein expression signatures for prediction of kidney disease progression.

  2009cited by this paper
• TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA.

  2007cited by this paper
• TGF-beta in renal injury and disease.

  2007cited by this paper
• Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation.

  2007cited by this paper
• The spectrum of podocytopathies: a unifying view of glomerular diseases.

  2007cited by this paper
• Differential Interactions between Transforming Growth Factor-β3/TβR1, TAB1, and CD2AP Disrupt Blood-Testis Barrier and Sertoli-Germ Cell Adhesion*

  2006cited by this paper
• Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation

  2006cited by this paper
• The podocyte's response to injury: role in proteinuria and glomerulosclerosis.

  2006cited by this paper
• Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy

  2006cited by this paper
• Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase*

  2005cited by this paper
• Non-Smad TGF-beta signals.

  2005cited by this paper
• TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.

  2005cited by this paper
• CD2AP Expression in a Renal Ischemia/Reperfusion Injury Model and Analysis of Its Related Genes Using Overexpression and RNA Interference Technique

  2005cited by this paper
• A Novel Role for the Adaptor Molecule CD2-associated Protein in Transforming Growth Factor-β-induced Apoptosis*

  2004cited by this paper
• Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells.

  2004cited by this paper
• New insights into TGF-β–Smad signalling

  2004cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Nephrin and CD2AP Associate with Phosphoinositide 3-OH Kinase and Stimulate AKT-Dependent Signaling

  2003cited by this paper
• TM4: a free, open-source system for microarray data management and analysis.

  2003cited by this paper
• CD2-Associated Protein Haploinsufficiency Is Linked to Glomerular Disease Susceptibility

  2003cited by this paper
• Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses*

  2003cited by this paper
• Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

  2003cited by this paper
• Hierarchical model of gene regulation by transforming growth factor β

  2003cited by this paper
• CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain.

  2001cited by this paper
• Apoptosis in podocytes induced by TGF-beta and Smad7.

  2001cited by this paper
• Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis.

  2001cited by this paper
• Differential Usage of Signal Transduction Pathways Defines Two Types of Serum Response Factor Target Gene*

  2001cited by this paper
• Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration*

  2000cited by this paper
• Controlling TGF-beta signaling.

  2000cited by this paper
• Role of Ras and Mapks in TGFbeta signaling.

  2000cited by this paper
• The Smad pathway.

  2000cited by this paper
• SRF‐dependent gene expression is required for PI3‐kinase‐regulated cell proliferation

  2000cited by this paper
• Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β

  1999cited by this paper
• Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators

  1998cited by this paper
• Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

  1997cited by this paper
• Regulation of differentiation by TGF-beta.

  1996cited by this paper
• GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex.

  1995cited by this paper
• Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

  1995cited by this paper
• The Transforming Growth Factor‐Betas: Past, Present, and Future

  1990cited by this paper
• Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells

  1988cited by this paper
• Transforming growth factors.

  1985cited by this paper

• A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells

  2017cites this paper
• Dexamethasone Inhibits Podocyte Apoptosis by Stabilizing the PI3K/Akt Signal Pathway

  2013cites this paper
• Novel Mechanisms and Roles of Glomerular Podocytes Upregulation of mitochondrial Nox 4 mediates TGF-- induced apoptosis in cultured mouse podocytes

  2013cites this paper
• Effects of TGF-β on Podocyte Growth and Disease Progression in Proliferative Podocytopathies

  2010cites this paper